Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients

Autor: Valentina D. A. Corino, Alessandra Marcantoni, Lisa Licitra, Ester Orlandi, Paolo Bossi, Laura D. Locati, Sara Valerini, Luca Bellanti, Aurora Mirabile, Iolanda De Martino, Toni Ibrahim, Stefania Vecchio, Salvatore Battaglia, Rebecca Romanò, Letizia Deantonio, Marco Ravanelli, Andrea Ferri, Tito Poli, Damiano Caruso, Fulvia Blengio, Marco Bologna, Salvatore Alfieri, Alberto Grammatica, Antonella Richetti, Achille Tarsitano, Enrica Grosso, Luca Mainardi, Giuseppina Calareso, Francesco Martucci
Přispěvatelé: Alfieri S., Romano R., Bologna M., Calareso G., Corino V., Mirabile A., Ferri A., Bellanti L., Poli T., Marcantoni A., Grosso E., Tarsitano A., Battaglia S., Blengio F., De Martino I., Valerini S., Vecchio S., Richetti A., Deantonio L., Martucci F., Grammatica A., Ravanelli M., Ibrahim T., Caruso D., Locati L.D., Orlandi E., Bossi P., Mainardi L., Licitra L.F.
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Pre treatment
medicine.medical_specialty
magnetic resonance imaging (MRI)
recurrence
Prognosi
Disease outcome
head and neck squamous cell carcinoma
030218 nuclear medicine & medical imaging
03 medical and health sciences
0302 clinical medicine
Retrospective Studie
medicine
Humans
Radiology
Nuclear Medicine and imaging

predictive
Retrospective Studies
magnetic resonance imaging (mri)
pretreatment
prognostic
radiomic
medicine.diagnostic_test
Head and Neck Neoplasm
business.industry
Squamous Cell Carcinoma of Head and Neck
Magnetic resonance imaging
Retrospective cohort study
Hematology
General Medicine
Radiomic
Magnetic Resonance Imaging
Prognosis
Head and Neck Neoplasms
Neoplasm Recurrence
Local

medicine.disease
Head and neck squamous-cell carcinoma
stomatognathic diseases
Neoplasm Recurrence
Local
Oncology
030220 oncology & carcinogenesis
Radiology
business
Human
Popis: Objectives: To identify and validate baseline magnetic resonance imaging (b-MRI) radiomic features (RFs) as predictors of disease outcomes in effectively cured head and neck squamous cell carcinoma (HNSCC) patients. Materials and methods: Training set (TS) and validation set (VS) were retrieved from preexisting datasets (HETeCo and BD2Decide trials, respectively). Only patients with both pre- and post-contrast enhancement T1 and T2-weighted b-MRI and at least 2years of follow-up (FUP) were selected. The combination of the best extracted RFs was used to classify low risk (LR) vs. high risk (HR) of disease recurrence. Sensitivity, specificity, and area under the curve (AUC) of the radiomic model were computed on both TS and VS. Overall survival (OS) and 5-year disease-free survival (DFS) Kaplan–Meier (KM) curves were compared for LR vs. HR. The radiomic-based risk class was used in a multivariate Cox model, including well-established clinical prognostic factors (TNM, sub-site, human papillomavirus [HPV]). Results: In total, 57 patients of TS and 137 of VS were included. Three RFs were selected for the signature. Sensitivity of recurrence risk classifier was 0.82 and 0.77, specificity 0.78 and 0.81, AUC 0.83 and 0.78 for TS and VS, respectively. VS KM curves for LR vs. HR groups significantly differed both for 5-year DFS (p
Databáze: OpenAIRE